Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Income Statement 2011–2025
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenue | 14.3M | 12.7M | 13.3M | 12.6M | 18.6M | 17.9M | 19.0M | 16.7M | 12.8M | 9.4M | 13.9M | 13.7M | 15.5M | 12.7M | 9.8M |
| Gross Profit | 5.5M | 4.7M | 4.5M | 4.0M | 6.6M | 8.1M | 8.9M | 7.3M | 5.7M | 2.6M | 7.3M | 8.4M | 10.7M | 8.7M | 6.1M |
| Profitability | |||||||||||||||
| Operating Income | -3.7M | -4.7M | -4.6M | -5.9M | -3.4M | -7.4M | -11.3M | -14.2M | -13.0M | -14.7M | -6.7M | -6.1M | -3.4M | -6.5M | -7.5M |
| EBITDA | -3.6M | -4.5M | -4.4M | -5.7M | -3.2M | -7.1M | -10.8M | -13.7M | -12.7M | -14.5M | -6.4M | -5.8M | -3.1M | -6.1M | -7.1M |
| Net Income | -3.5M | -4.8M | -5.2M | -5.1M | -4.0M | -3.3M | -11.8M | -14.3M | 9.3M | -10.2M | -8.2M | 3.7M | -5.4M | -7.3M | -7.9M |
| Per Share Data | |||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 1M | 0M | 3M | 0M | 2M | 2M | 1M | 1M | 4M | 4M | 10M | 7M | 5M | 4M | 27M |
Sonoma Pharmaceuticals Inc. Income Statement — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) income statement over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNOA's income statement history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.